Morgan Stanley (MS) 13D/13G Filings for Stoke Therapeutics, Inc. (STOK)

Morgan Stanley 13D and 13G filings for Stoke Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime		 Transaction
Date		 Type Company
Symbol		 Filed By
Symbol		 Shares Owned
% Owned		 Shares Vs. Prev Report View
2025-02-03
4:36 pm
Purchase		 2024-12-31 13G Stoke Therapeutics, Inc.
STOK		 MORGAN STANLEY
MS		 3,426,739
6.500%		 68,364increase
(+2.04%)		 Filing
2024-02-09
2:51 pm
Purchase		 2023-12-31 13G Stoke Therapeutics, Inc.
STOK		 MORGAN STANLEY
MS		 3,358,375
7.500%		 910,161increase
(+37.18%)		 Filing
2023-02-10
11:50 am
Purchase		 2022-12-30 13G Stoke Therapeutics, Inc.
STOK		 MORGAN STANLEY
MS		 2,448,214
6.200%		 2,448,214increase
(New Position)		 Filing